These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 10930986

  • 1. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments.
    Sheu JR, Hung WC, Wu CH, Lee YM, Yen MH.
    Br J Haematol; 2000 Jul; 110(1):110-5. PubMed ID: 10930986
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.
    Hsiao G, Yen MH, Lee YM, Sheu JR.
    Br J Haematol; 2002 Jun; 117(3):699-704. PubMed ID: 12028044
    [Abstract] [Full Text] [Related]

  • 3. Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
    Sheu JR, Hsiao G, Lee YM, Yen MH.
    Int J Hematol; 2001 Apr; 73(3):393-8. PubMed ID: 11345210
    [Abstract] [Full Text] [Related]

  • 4. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR, Chao SH, Yen MH, Huang TF.
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [Abstract] [Full Text] [Related]

  • 5. Antithrombotic effects of magnesium sulfate in in vivo experiments.
    Sheu JR, Hsiao G, Shen MY, Lee YM, Yen MH.
    Int J Hematol; 2003 May; 77(4):414-9. PubMed ID: 12774935
    [Abstract] [Full Text] [Related]

  • 6. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):161-6. PubMed ID: 9059849
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo.
    Hsiao G, Shen MY, Lin KH, Chou CY, Tzu NH, Lin CH, Chou DS, Chen TF, Sheu JR.
    Eur J Pharmacol; 2003 Apr 04; 465(3):281-7. PubMed ID: 12681440
    [Abstract] [Full Text] [Related]

  • 8. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.
    Sheu JR, Yen MH, Peng HC, Chang MC, Huang TF.
    Eur J Pharmacol; 1995 Dec 27; 294(1):231-8. PubMed ID: 8788436
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
    Sheu JR, Hung WC, Lee YM, Yen MH.
    Eur J Pharmacol; 1996 Dec 30; 318(2-3):469-75. PubMed ID: 9016940
    [Abstract] [Full Text] [Related]

  • 10. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
    Sheu JR, Kan YC, Hung WC, Su CH, Lin CH, Lee YM, Yen MH.
    Thromb Res; 1998 Oct 15; 92(2):53-64. PubMed ID: 9792112
    [Abstract] [Full Text] [Related]

  • 11. Rutaecarpine, an Alkaloid from Evodia rutaecarpa, Can Prevent Platelet Activation in Humans and Reduce Microvascular Thrombosis in Mice: Crucial Role of the PI3K/Akt/GSK3β  Signal Axis through a Cyclic Nucleotides/VASP-Independent Mechanism.
    Huang CJ, Huang WC, Lin WT, Shu LH, Sheu JR, Tran OT, Hsia CW, Jayakumar T, Bhavan PS, Hsieh CY, Chang CC.
    Int J Mol Sci; 2021 Oct 15; 22(20):. PubMed ID: 34681769
    [Abstract] [Full Text] [Related]

  • 12. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
    Tian KM, Li JJ, Xu SW.
    Pharmacol Res; 2019 Mar 15; 141():541-550. PubMed ID: 30616017
    [Abstract] [Full Text] [Related]

  • 13. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
    Lee SK, Kim NH, Lee J, Kim DH, Lee ES, Choi HG, Chang HW, Jahng Y, Jeong TC.
    Planta Med; 2004 Aug 15; 70(8):753-7. PubMed ID: 15326550
    [Abstract] [Full Text] [Related]

  • 14. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa.
    Moon TC, Murakami M, Kudo I, Son KH, Kim HP, Kang SS, Chang HW.
    Inflamm Res; 1999 Dec 15; 48(12):621-5. PubMed ID: 10669112
    [Abstract] [Full Text] [Related]

  • 15. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
    Ueng YF, Tsai TH, Don MJ, Chen RM, Chen TL.
    J Pharm Pharmacol; 2005 Feb 15; 57(2):227-32. PubMed ID: 15720787
    [Abstract] [Full Text] [Related]

  • 16. Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
    Tsai TH, Chang CH, Lin LC.
    Planta Med; 2005 Jul 15; 71(7):640-5. PubMed ID: 16041650
    [Abstract] [Full Text] [Related]

  • 17. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa.
    Ueng YF, Wang JJ, Lin LC, Park SS, Chen CF.
    Life Sci; 2001 Nov 30; 70(2):207-17. PubMed ID: 11787945
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH, Suh DY, Yang HO, Park YH, Kang YH, Kim YC.
    Arzneimittelforschung; 1994 Oct 30; 44(10):1122-6. PubMed ID: 7818584
    [Abstract] [Full Text] [Related]

  • 19. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors.
    Kobayashi Y, Hoshikuma K, Nakano Y, Yokoo Y, Kamiya T.
    Planta Med; 2001 Apr 30; 67(3):244-8. PubMed ID: 11345696
    [Abstract] [Full Text] [Related]

  • 20. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
    Su XL, Su W, Wang Y, Wang YH, Ming X, Kong Y.
    Acta Pharmacol Sin; 2016 Sep 30; 37(9):1208-17. PubMed ID: 27424653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.